IMA
ImageneBio, Inc.
NASDAQ: IMA · HEALTHCARE · BIOTECHNOLOGY
$6.02
+1.52% today
Updated 2026-04-30
Market cap
$65.21M
P/E ratio
—
P/S ratio
81.51x
EPS (TTM)
$-9.64
Dividend yield
—
52W range
$4 – $18
Volume
0.4M
ImageneBio, Inc. (IMA) Financial statements
SEC filings — annual and quarterly data.
Profit margin
0.00%
Operating margin
-6,056.00%
ROE
-68.90%
ROA
-35.90%
Debt/equity
0.08x
Margin trends — annual
Gross margin Operating margin Profit margin
| Year | Revenue | Net income | Gross margin | Op. margin | Profit margin |
|---|---|---|---|---|---|
| 2018 | $990000.00 | $-40.87M | -3,837.98% | -4,130.71% | -4,127.78% |
| 2019 | $13.75M | $-16.82M | -81.33% | -134.46% | -122.28% |
| 2020 | $9.19M | $-44.26M | -387.79% | -484.22% | -481.36% |
| 2021 | $30.98M | $-34.12M | -52.03% | -110.18% | -110.10% |
| 2022 | $15.62M | $-68.77M | -311.84% | -453.99% | -440.29% |
| 2023 | $9.16M | $-68.17M | 88.86% | -823.33% | -744.17% |
| 2024 | $3.50M | $-36.57M | 100.00% | -1,057.14% | -1,044.80% |
| 2025 | $800000.00 | $-45.35M | -29.13% | -6,056.38% | -5,668.63% |